249 related articles for article (PubMed ID: 35398033)
1. Colorectal neoplasia prevalence in a predominantly Hispanic community: Results from a colorectal cancer screening program in Texas.
Willauer AN; Zuckerman MJ; Alomari A; Alvarado LA; Salaiz R; Casner N; Dwivedi AK; Shokar NK
Am J Med Sci; 2022 Oct; 364(4):394-403. PubMed ID: 35398033
[TBL] [Abstract][Full Text] [Related]
2. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.
Carballal S; Sánchez A; Moreira L; Cuellar-Monterrubio JE; Bernuy J; Daca M; Ortiz O; Ocaña T; Rivero-Sánchez L; Jung G; Serradesanferm A; Pozo A; Grau J; Torá I; Zaffalon D; Castells A; Pellisé M; Balaguer F;
Endoscopy; 2022 Jul; 54(7):688-697. PubMed ID: 34607378
[TBL] [Abstract][Full Text] [Related]
4. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
[TBL] [Abstract][Full Text] [Related]
5. Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps.
Zorzi M; Battagello J; Amidei CB; Antonelli G; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rizzotto ER; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rugge M; ; Hassan C
Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1518-1527.e7. PubMed ID: 38325601
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
7. Adenoma and advanced neoplasia detection rates increase from 45 years of age.
Karsenti D; Tharsis G; Burtin P; Venezia F; Tordjman G; Gillet A; Samama J; Nahon-Uzan K; Cattan P; Cavicchi M
World J Gastroenterol; 2019 Jan; 25(4):447-456. PubMed ID: 30700941
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
9. Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly Hispanic community.
Shokar NK; Byrd T; Salaiz R; Flores S; Chaparro M; Calderon-Mora J; Reininger B; Dwivedi A
Prev Med; 2016 Oct; 91():273-280. PubMed ID: 27575314
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
12. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
[TBL] [Abstract][Full Text] [Related]
13. Fecal Immunologic Test Results and Diagnostic Colonoscopy in a Mexican Population at Average Risk for Colorectal Cancer.
Manzano-Robleda MDC; Espinosa-Tamez P; Potter MB; Lajous M; Van Loon K; Zhang L; Jimenez-Peña A; Sánchez Del Monte J; Mohar A; Hernández-Guerrero A
Cancer Prev Res (Phila); 2020 Nov; 13(11):959-966. PubMed ID: 32655008
[TBL] [Abstract][Full Text] [Related]
14. Advanced serrated polyps as a target of screening: detection rate and positive predictive value within a fecal immunochemical test-based colorectal cancer screening population.
van Toledo DEFWM; Breekveldt ECH; IJspeert JEG; van Vuuren AJ; van Kemenade FJ; Ramakers C; Nagtegaal ID; van Leerdam ME; Spaander MCW; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Dekker E
Endoscopy; 2023 Jun; 55(6):526-534. PubMed ID: 36323332
[TBL] [Abstract][Full Text] [Related]
15. Fecal-based colorectal cancer screening among the uninsured in northern Manhattan.
Hillyer GC; Schmitt KM; Freedberg DE; Kramer RA; Su Y; Rosenberg RM; Neugut AI
Am J Prev Med; 2014 Aug; 47(2):182-7. PubMed ID: 24951037
[TBL] [Abstract][Full Text] [Related]
16. Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program.
Wassie MM; Young GP; Winter JM; Cock C; Bampton P; Rahman M; Heddle R; Fraser R; Meng R; Symonds EL
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2389-2398.e2. PubMed ID: 36610499
[TBL] [Abstract][Full Text] [Related]
17. What are the contextual risk factors for low colorectal cancer screening uptake in El Paso County, Texas? Spatial cross-sectional analysis.
Salinas J; Brito J; Rincones C; Shokar NK
BMJ Open; 2020 Oct; 10(10):e038342. PubMed ID: 33040009
[TBL] [Abstract][Full Text] [Related]
18. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
Lieberman D; Sullivan BA; Hauser ER; Qin X; Musselwhite LW; O'Leary MC; Redding TS; Madison AN; Bullard AJ; Thomas R; Sims KJ; Williams CD; Hyslop T; Weiss D; Gupta S; Gellad ZF; Robertson DJ; Provenzale D
Gastroenterology; 2020 Mar; 158(4):862-874.e8. PubMed ID: 31376388
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and characteristics of colonic polyps and adenomas in 2654 colonoscopies in Saudi Arabia.
Almadi MA; Alharbi O; Azzam N; Wadera J; Sadaf N; Aljebreen AM
Saudi J Gastroenterol; 2014; 20(3):154-61. PubMed ID: 24976278
[TBL] [Abstract][Full Text] [Related]
20. Ethnic and sex disparities in colorectal neoplasia among Hispanic patients undergoing screening colonoscopy.
Lathroum L; Ramos-Mercado F; Hernandez-Marrero J; Villafaña M; Cruz-Correa M
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):997-1001. PubMed ID: 22542749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]